{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Semler Scientific, Inc.
Semler Scientific Hits New 52-Week Low at $18.45 Amid Ongoing Struggles
Semler Scientific, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. The company has reported negative results for four consecutive quarters, with key financial metrics indicating struggling operational performance. Its market capitalization stands at USD 425 million, with no dividends offered.
Semler Scientific Hits 52-Week Low at $19.54 Amid Ongoing Decline
Semler Scientific, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company, with a market capitalization of USD 425 million, has reported negative financial results for four consecutive quarters, impacting key metrics like operating cash flow and net sales.
Semler Scientific Hits New 52-Week Low at $19.56 Amidst Significant Decline
Semler Scientific, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 425 million, has reported negative results for four consecutive quarters and has low operating cash flow and net sales.
Semler Scientific Stock Plummets to New 52-Week Low of $21.56
Semler Scientific, Inc. has hit a new 52-week low, reflecting a significant decline over the past year. The company, with a market cap of approximately USD 425 million, has reported negative financial results for four consecutive quarters, including low operating cash flow and net sales.
Semler Scientific, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape
Semler Scientific, Inc. has recently adjusted its valuation metrics, reporting a P/E ratio of 24 and a price-to-book value of 2.32. Compared to peers like Axogen and Standard BioTools, which face financial challenges, Semler's performance indicators suggest a relatively stable position in a competitive market.
Semler Scientific Hits 52-Week Low at $21.84 Amid Ongoing Struggles
Semler Scientific, Inc. has hit a new 52-week low, reflecting a significant decline over the past year. The company, with a market capitalization of USD 425 million, has reported negative financial results for four consecutive quarters, with operating cash flow and net sales at their lowest levels.
Semler Scientific Hits New 52-Week Low at $23.51 Amid Declining Performance
Semler Scientific, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company has reported negative financial results for four consecutive quarters, with low net sales and operating cash flow, while maintaining a market capitalization of USD 425 million.
Is Semler Scientific, Inc. technically bullish or bearish?
As of August 19, 2025, Semler Scientific, Inc. is in a bearish trend, indicated by negative signals from MACD, RSI, and moving averages, with a year-to-date return of -45.39% compared to the S&P 500's 12.22%.
Is Semler Scientific, Inc. overvalued or undervalued?
As of August 4, 2025, Semler Scientific, Inc. has improved from a risky to an attractive valuation grade, appearing undervalued with a P/E ratio of 24, despite a year-to-date stock performance of -45.39% compared to the S&P 500's 12.22%.
Is Semler Scientific, Inc. overvalued or undervalued?
As of May 13, 2025, Semler Scientific, Inc. is considered overvalued with a valuation grade shift from attractive to risky, reflected in its high P/E ratio of 24 and a year-to-date decline of -22.25%, despite a 14.56% return over the past year that outperformed the S&P 500.
Is Semler Scientific, Inc. technically bullish or bearish?
As of June 18, 2025, the trend is mildly bearish due to daily moving averages, despite some bullish signals from weekly and monthly indicators like MACD and Bollinger Bands, suggesting caution in the current market.
What does Semler Scientific, Inc. do?
Semler Scientific, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $9 million and a net profit of -$65 million. It has a market cap of $324.27 million and key metrics include a P/E ratio of 24.00 and a return on equity of 9.82%.
How big is Semler Scientific, Inc.?
As of Jun 18, Semler Scientific, Inc. has a market capitalization of 324.27 million, with net sales of 49.22 million and a net profit of -29.87 million over the last four quarters. Shareholder's funds are reported at 230.75 million, and total assets amount to 243.04 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
